ProfileGDS4718 / 1559706_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 3% 6% 7% 4% 8% 4% 10% 5% 8% 6% 7% 4% 13% 6% 7% 11% 4% 12% 15% 12% 7% 8% 13% 5% 9% 5% 2% 11% 18% 7% 8% 9% 6% 3% 15% 14% 5% 7% 4% 7% 6% 14% 10% 5% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.503063
GSM549102patient 115, normal, homogenized [OPG study]3.647056
GSM549104patient 119, normal, homogenized [OPG study]3.631587
GSM549108patient 138, normal, homogenized [OPG study]3.554524
GSM549119patient 077, normal, homogenized [OPG study]3.695828
GSM549133patient 032, cancer, homogenized [OPG study]3.512124
GSM549139patient 042, cancer, homogenized [OPG study]3.7497910
GSM549099patient 107, normal, homogenized [OPG study]3.590855
GSM549109patient 139, normal, homogenized [OPG study]3.73668
GSM549110patient 046, normal, homogenized [OPG study]3.616446
GSM549114patient 063, normal, homogenized [OPG study]3.638767
GSM549122patient 082, normal, homogenized [OPG study]3.526154
GSM549134patient 033, cancer, homogenized [OPG study]3.89713
GSM549136patient 036, cancer, homogenized [OPG study]3.593716
GSM549140patient 044, cancer, homogenized [OPG study]3.639877
GSM549111patient 047, normal, homogenized [OPG study]3.7841911
GSM549113patient 057, normal, homogenized [OPG study]3.515184
GSM549132patient 031, cancer, homogenized [OPG study]3.8307212
GSM549137patient 038, cancer, homogenized [OPG study]3.9420815
GSM549142patient 047, cancer, homogenized [OPG study]3.9085212
GSM549100patient 110, normal, homogenized [OPG study]3.67437
GSM549107patient 135, normal, homogenized [OPG study]3.69158
GSM549115patient 068, normal, homogenized [OPG study]3.8512113
GSM549116patient 072, normal, homogenized [OPG study]3.578695
GSM549120patient 078, normal, homogenized [OPG study]3.730159
GSM549131patient 030, cancer, homogenized [OPG study]3.546965
GSM549118patient 074, normal, homogenized [OPG study]3.470592
GSM549129patient 027, cancer, homogenized [OPG study]3.8283111
GSM549123patient 088, normal, homogenized [OPG study]4.0854618
GSM549124patient 006, cancer, homogenized [OPG study]3.697697
GSM549126patient 015, cancer, homogenized [OPG study]3.701388
GSM549128patient 025, cancer, homogenized [OPG study]3.730139
GSM549103patient 117, normal, homogenized [OPG study]3.629716
GSM549117patient 073, normal, homogenized [OPG study]3.528863
GSM549138patient 041, cancer, homogenized [OPG study]3.9274715
GSM549141patient 045, cancer, homogenized [OPG study]3.8839714
GSM549130patient 028, cancer, homogenized [OPG study]3.58365
GSM549101patient 111, normal, homogenized [OPG study]3.671747
GSM549105patient 128, normal, homogenized [OPG study]3.545174
GSM549106patient 134, normal, homogenized [OPG study]3.629727
GSM549112patient 048, normal, homogenized [OPG study]3.632546
GSM549125patient 011, cancer, homogenized [OPG study]3.922714
GSM549127patient 024, cancer, homogenized [OPG study]3.7666110
GSM549135patient 035, cancer, homogenized [OPG study]3.542525